Invitae Corporation Operating Cash Flow 2011-2026 | NVTA

Annual Operating Cash Flow Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-493 M	-560 M	-299 M	-145 M	-92.2 M	-98 M	-76.3 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-76.3 M	-560 M	-252 M

Quarterly Operating Cash Flow Invitae Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-156 M	-89.3 M	-34.4 M	-	-411 M	-282 M	-148 M	-	-384 M	-219 M	-89.5 M	-	-185 M	-123 M	-62.4 M	-	-97.8 M	-61.1 M	-28.4 M	-	-76.7 M	-58.7 M	-32.9 M	-	-66.7 M	-41.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-28.4 M	-411 M	-132 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 205.36	0.42 %	$ 22.8 B	USA
Celcuity CELC	-153 M	$ 87.98	-4.98 %	$ 4.11 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-29.1 M	$ 4.24	-5.89 %	$ 5.64 M	USA
Fulgent Genetics FLGT	-102 M	$ 19.11	3.32 %	$ 588 M	USA
Castle Biosciences CSTL	64.3 M	$ 21.21	0.62 %	$ 615 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-24.2 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	1.04 B	$ 150.56	-0.83 %	$ 11.8 B	Irlanda
Illumina ILMN	1.08 B	$ 165.51	3.42 %	$ 25.7 B	USA
Guardant Health GH	-185 M	$ 131.53	1.08 %	$ 16.5 B	USA
CareDx, Inc CDNA	42 M	$ 23.02	1.16 %	$ 1.23 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	5.83 M	$ 1.79	2.87 %	$ 7.92 M	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-9.68 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-460 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	390 M	$ 101.92	1.94 %	$ 6.88 B	USA
Charles River Laboratories International CRL	738 M	$ 190.17	0.09 %	$ 9.43 B	USA
Pacific Biosciences of California PACB	-111 M	$ 1.4	1.82 %	$ 420 M	USA
Medpace Holdings MEDP	713 M	$ 472.3	1.18 %	$ 13.6 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	956 M	$ 1 142.15	-1.79 %	$ 23.5 B	Schweiz
NeoGenomics NEO	5.23 M	$ 11.7	2.27 %	$ 1.5 B	USA
Myriad Genetics MYGN	1.8 M	$ 4.61	1.43 %	$ 427 M	USA
National Research Corporation NRC	26.4 M	$ 20.71	4.86 %	$ 464 M	USA
Natera NTRA	215 M	$ 219.39	-1.54 %	$ 30 B	USA
Personalis PSNL	-74.9 M	$ 9.94	1.95 %	$ 887 M	USA
Senseonics Holdings SENS	-59.1 M	$ 7.31	-1.62 %	$ 305 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Biomerica BMRA	-3.84 M	$ 2.03	-1.02 %	$ 4.66 M	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 69.19	-1.24 %	$ 4.14 B	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 273.61	0.89 %	$ 22.8 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 487.41	-1.4 %	$ 184 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.68	1.63 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 9.27	-0.22 %	$ 2.01 B	USA
Waters Corporation WAT	653 M	$ 368.52	-0.66 %	$ 21.9 B	USA